Rohto Pharmaceutical, a leading Japanese pharmaceutical company, is dedicated to global health and well-being. The company develops and distributes innovative products in areas such as eye drops, skincare, and digestive medicine. With a focus on research and quality, Rohto Pharmaceutical offers high-quality solutions for consumers worldwide, driving advancements in health and personal care.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Rohto Pharmaceutical is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Rohto Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 47.14 JPY.
Across its last 5 earnings reports, Rohto Pharmaceutical stock moved by ±1.2% on average the following day. The largest reaction was +2.5% on 08/06/2026; 5 of 5 reactions were positive.
Rohto Pharmaceutical has beaten analyst EPS estimates in 2 of its last 4 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.